Unlock stock picks and a broker-level newsfeed that powers Wall Street.
11.66
-2.04
(-14.89%)
At close: April 4 at 5:29:53 PM GMT+2
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-23,909
-27,227
-21,043
-18,640
-17,569
Investing Cash Flow
-208
--
-1,136
-772
-331
Financing Cash Flow
34,170
5,533
25,942
21,306
28,263
End Cash Position
17,575
2,763
24,457
20,694
18,800
Capital Expenditure
--
--
-1,136
-772
-331
Issuance of Capital Stock
39,337
3,871
31,664
23,202
37,189
Repayment of Debt
--
--
--
--
-5,000
Free Cash Flow
-23,909
-27,227
-22,179
-19,412
-17,900
12/31/2020 - 4/18/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
LPGO.ST Lipigon Pharmaceuticals AB (publ)
0.1264
+6.94%
ANNX.ST Annexin Pharmaceuticals AB (publ)
0.3040
-1.62%
CANTA.ST Cantargia AB (publ)
1.2950
-2.04%
ATORX.ST Alligator Bioscience AB (publ)
0.0055
-9.84%
5KW.F SkinBioTherapeutics plc
0.2620
-6.43%
2HA.MU Spero Therapeutics Inc
0.5750
-10.99%
ZH6.BE Biohaven Ltd. R
17.10
-8.56%
HQ1.MU Oruka Therapeutics Inc. R
8.25
-6.25%
CHOSA.ST CHOSA Oncology AB
0.6680
-4.57%
SIMRIS-B.ST Simris Group AB (PUBL)
0.1105
-1.34%